Loading
A phase 2 trial of CivaSheet in advanced solid tumours, run by CivaTech Oncology, now recruiting.
Feasibility Study to Treat Lung Cancer With the Permanently Implantable LDR CivaSheet® is a phase 2 interventional study registered as NCT03290534 by CivaTech Oncology, with 40 participants planned, started 2019-03-13 and due to reach its primary completion in 2026-12. Interventions recorded: CivaSheet.
The full inclusion and exclusion criteria are on the registry record. Read 2026-10-07. Recruiting overall does not mean a particular site is open; ask the study team.
ClinicalTrials.gov data courtesy of the US National Library of Medicine.
Shares CivaTech Oncology and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Shares Metastatic cancer (cancer that has spread) and the tag pipeline.
Every source this page cites, grouped by who published it. Grouping is read from the web address, not assigned by hand.
A source that has moved or gone is reported by the weekly link check. /audit/